Historique de carrière de Ed Margerrison
Anciens postes connus de Ed Margerrison
Sociétés | Poste | Début | Fin |
---|---|---|---|
CHITOGENX INC. | Directeur Général | 09/12/2015 | 18/10/2016 |
President | 09/12/2015 | 18/10/2016 | |
Akela Pharma, Inc.
Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Akela Pharma, Inc. operates as a drug development company, which develops and manufactures pharmaceutical formulations and drugs. The company operates as a specialty contract pharmaceutical formulation developer and clinical and commercial drug manufacturer for proprietary drug products through its wholly-owned subsidiary, PharmaForm LLC, a pharmaceutical intellectual property development company. It provides specialty contract services in the area of pharmaceutical dosage form development, preclinical, scale-up, clinical and commercial supply manufacturing, focusing on controlled release and bioavailability enhancement technologies, such as hot melt extrusion, spray drying and liquid filled capsules. Akela Pharma was founded on November 15, 1988 and is headquartered in Austin, TX. | Corporate Officer/Principal | 04/09/2009 | - |
Formation de Ed Margerrison
St. George's University of London | Doctorate Degree |
The Queen's College (Great Britain) | Undergraduate Degree |
Statistiques
Internationale
Royaume-Uni | 3 |
Etats-Unis | 2 |
Canada | 2 |
Opérationnelle
Corporate Officer/Principal | 1 |
Chief Executive Officer | 1 |
President | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
CHITOGENX INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Akela Pharma, Inc.
Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Akela Pharma, Inc. operates as a drug development company, which develops and manufactures pharmaceutical formulations and drugs. The company operates as a specialty contract pharmaceutical formulation developer and clinical and commercial drug manufacturer for proprietary drug products through its wholly-owned subsidiary, PharmaForm LLC, a pharmaceutical intellectual property development company. It provides specialty contract services in the area of pharmaceutical dosage form development, preclinical, scale-up, clinical and commercial supply manufacturing, focusing on controlled release and bioavailability enhancement technologies, such as hot melt extrusion, spray drying and liquid filled capsules. Akela Pharma was founded on November 15, 1988 and is headquartered in Austin, TX. | Health Technology |
- Bourse
- Insiders
- Ed Margerrison
- Expérience